🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Several experts said the popularity for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the service has taken down violative content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Item Details and Pricing

Within these groups, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to possibly serious health risks”.